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Background: A near-universal finding internationally is that patient valuations of their own health, represented
using the EQ-5D system, are mostly higher than general population valuations of the same EQ-5D states. This paper
investigates whether this result also applies to New Zealand. Despite the EQ-5D’s widespread use for cost-utility
analysis in New Zealand, in particular by the Pharmaceutical Management Agency (PHARMAC) for health technology
assessments, no previous studies comparing patient and general population valuations have included data for New
Zealand.
Methods: Valuations of 13 EQ-5D health states from a 1999 survey of the New Zealand general population
(n = 396) are compared with injured New Zealanders’ (n = 2099) valuations of their own health (also represented on
the EQ-5D) collected between 2007 and 2009 in the Prospective Outcomes of Injury Study. Which EQ-5D dimensions
are most strongly associated with the population valuations is also investigated.
Results: Injured population valuations are higher (better-rated health) than general population valuations for all 13
health states considered except 11111 (no problems on any EQ-5D dimension). This difference, which tends to be lar-
ger the ‘worse’ the state, is statistically significant at the 10% level for most of the states. State 11111 is rated
significantly lower by the injured population than the general population. Pain/discomfort is more important in
determining valuations for the general population than for injured people, whereas problems with self-care are more
important for the injured population; anxiety/depression is important in both general and injured population valuations.
Conclusions: Consistent with the international literature, injured people’s valuations of their own health are mostly higher
than the general population’s hypothetical valuations of the same EQ-5D states for New Zealand. These differences are
practically significant in the sense that they are larger than minimally important differences for the EQ-5D from the
literature, and they appear capable of significantly affecting CUA results.
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Fundamental to measuring Quality-Adjusted Life Years
(QALYs), as used for cost-utility analysis (CUA), are
value sets for health states representing health-related
quality of life (HRQoL). A value set comprises HRQoL
values for all possible health states representable by the
health state classification system concerned – of which
well-known examples include the EQ-5D [1], HUI [2]* Correspondence: paul.hansen@otago.ac.nz
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unless otherwise stated.and SF-6D [3]. Most systems’ values range between unity
for ‘perfect health’ and zero for ‘dead’, with negative
values for states considered worse than dead.
Value sets are created by asking interview or survey
participants to value a subset of the system’s health
states and then regression models are used to interpolate
values for the full set of states. Standard practice is for
participants to be drawn from the general population, in
their dual roles as tax-payers and potential patients
[4-6]. Thus value sets are derived from valuations mostly
for hypothetical health states that participants are not
personally familiar with and are required to imagine.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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tients – i.e. people with direct personal experience of ill-
ness or injury – assign different health state valuations
than the general population [7,8]. A literature review by
De Wit et al. [9] and a meta-analysis by Peeters et al.
[10] concluded that patients’ valuations of their own
(actual) health states tend to be higher than hypothetical
valuations of descriptions of the same states by the gen-
eral population. In contrast, however, a meta-analysis by
Dolders et al. [11], despite finding some evidence for
such relationships, found no statistically significant dif-
ferences overall.
Most studies in the above-mentioned literature pertain to
European and North American countries. To our know-
ledge, no studies comparing patient and general population
valuations include data for New Zealand. And yet the
EQ-5D system and Devlin et al.’s value set [12], which
is based on valuations from a 1999 survey of the New
Zealand general population, is widely used for CUA
in New Zealand, in particular by the Pharmaceutical
Management Agency (PHARMAC) for health technol-
ogy assessments [6]. It would be useful to know, there-
fore, whether the above-mentioned international finding
that patient valuations tend to exceed general popula-
tion valuations also applies to New Zealand.
In addition, most previous studies have sampled pa-
tients with illnesses such as cancer or stroke rather than
injuries (as we do in this paper). It is possible that valua-
tions may differ between people experiencing an illness
(often accompanied by an ongoing decline in health prior
to clinical diagnosis) and those experiencing an acute-
onset change in health status, as caused by injury.
This paper compares Devlin et al.’s general population
valuations from the 1999 survey with injured New Zeal-
anders’ valuations of their own health (also represented
on the EQ-5D). The latter valuations were collected be-
tween 2007 and 2009 in the Prospective Outcomes of
Injury Study [13,14]. We also investigate which of the
EQ-5D’s dimensions are most strongly associated with the
injured population valuations and compare the results
with equivalent findings from the 1999 general population
study.
Methods
Measurement of health state preferences
In both the injured population and general population
studies (explained in turn below), health states were rep-
resented using the EQ-5D system and participants’
health state preferences were elicited using the visual
analogue scale (VAS) method.
Developed by the EuroQol Group, the EQ-5D system
represents HRQoL in terms of five dimensions – mobility,
self-care, usual activities, pain/discomfort and anxiety/de-
pression – where each dimension has three possible levelsof experience: (1) no problems, (2) moderate problems
and (3) extreme problems [1]. The three levels combine
across the five dimensions to define 243 health states, each
representable by a five-digit combination relating to the
relevant level within each dimension listed in the order
above (e.g. 11111 represents no problems on any dimen-
sion). The EQ-5D has been widely used in studies of in-
jury and illness [15,16].
Participants in both studies were asked to indicate on
a VAS depicted as a vertical line marked from 0 (“worst
imaginable health state”) to 100 (“best imaginable health
state”) where they considered the relevant states were
for them. Despite lacking the theoretical underpinnings
of the standard gamble or time trade-off methods, the
VAS has been empirically verified as a valid method for
eliciting health state valuations [17,18].
Injured population study
Injured New Zealanders’ valuations of their own health
on the EQ-5D were obtained from the Prospective Out-
comes of Injury Study (POIS), a prospective cohort
study of injured people aged between 18 and 64 years
[13,14]. POIS participants were recruited from entitle-
ment claims registered between December 2007 and
June 2009 with the Accident Compensation Corporation,
New Zealand’s government-controlled, no-fault injury
compensation insurance scheme. All injury types and a
wide range of severities were eligible for recruitment to
POIS, except for people whose injuries resulted from
self-harm or sexual assault.
POIS participants (n = 2856) completed a first inter-
view 3.2 months after injury, with follow-up interviews
4.6 and 12.3 months (medians) after injury. At each
interview, participants were asked to represent their own
health on the EQ-5D’s five dimensions and then to rate
it on a VAS.
General population study
The general population valuations of EQ-5D health
states come from a self-completed postal survey admin-
istered to 3000 adult New Zealanders randomly selected
from the electoral roll in 1999 [12] (also see [19] and
[20]). Three versions of the survey questionnaire were
administered, where each version comprised 13 or 14
different health states to be valued on two VAS, with
some states repeated across two or more of the versions.
Overall, valuations for 23 different health states were
collected. For each state, when arriving at their valuation
participants were instructed to imagine that it lasts for
one year and to disregard what may happen afterwards.
Although 1360 responses were received (a 50% re-
sponse rate of those who received the survey), 441 were
unusable due to: too few health states being valued
(because the valuation of so few states undermines
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health, or all states being valued the same (considered to be
implausible representations of a participant’s preferences).
Also, in order to ensure that only data with the strongest
claim to validity were analysed, following the approach rec-
ommended by Devlin et al. [12], we excluded a further
523 responses that had two or more logical inconsisten-
cies in their valuations, where a ‘logical inconsistency’ oc-
curs when a health state with a less severe problem on a
particular dimension than another state, given its prob-
lems on the other dimensions are no more severe, is
scored lower (e.g. state 21111 scored below 22111 would
be logically inconsistent). The remaining 396 responses
represent the highest quality data possible albeit one in-
consistency is permitted in order to ensure a reasonable
sample size (only 189 responses had no inconsistencies).
In order to calculate health utility values, Devlin et al.
rescale each respondent’s valuations to lie on a scale from
0 (representing death) to 1 (representing full health). As
hypothetical valuations for death and full health were not
collected for POIS participants, we are unable to do a
similar rescaling for these data. We therefore use the raw
valuations (without rescaling) from the general population
study to allow for direct comparisons between the general
population and injury population.
Analyses
Our choice of the appropriate samples from the injured
population and general population studies to include in
the present analysis was determined primarily by the avail-
ability of matching health states for which valuation data
were collected – to allow comparison between samples –
rather than matching the samples in terms of their socio-
demographic characteristics. International evidence has
shown that the usual socio-demographic and background
variables have no, or at most weak, impact on individual’s
health state valuations [11,21,22].
Thus, of the 23 health states for which valuations were
collected in the general population study, our protocol
was to include only those states which at least two people
(in practice, four) from the injured population study re-
ported as their own health state. For each of these health
states, an independent samples t-test was used to deter-
mine whether the mean valuations from the two studies
are statistically significantly different. Robust standard er-
rors were used for each of these tests to allow for the pos-
sibility of clustering at the individual level (as each
individual could value the same health state at multiple
time periods), and critical values were adjusted, using the
Holm-Bonferroni correction, to account for the large
number of comparisons performed.
In addition, to investigate which of the five EQ-5D di-
mensions are most strongly associated with the injured
population valuations, we estimated equations (1) and(2) below. These two equations are analogous to the
equations used to derive Devlin et al.’s two value sets
[12], both of which were selected after extensive testing
of a wide range of linear and non-linear specifications,
following the modelling approach used by Dolan [23].
100−VASit ¼ β0 þ β1MOit þ β2SCit þ β3UAit
þβ4PDit þ β5ADit þ ci þ uit
ð1Þ
100−VASit ¼ β0 þ β1MOit þ β2SCit þ β3UAit
þβ4PDit þ β5ADit þ β6N3it
þci þ uit ;
ð2Þ
where subscript i indexes individuals and t indexes time
periods (interviews).
Both equations were estimated with individual fixed
effects. Equation (1) is a linear main effects model in
which the effect of changes between levels 1 and 2 and
levels 2 and 3 (see Table 1 below) is constrained to being
identical. Equation (2) is an extension of equation (1), in
which an additional detriment to health is introduced if
any of the EQ-5D dimensions are at level 3 (extreme
problems). The dummy variables to represent each of
these effects are described in Table 1.
As explained in Devlin et al. [12], because the EQ-5D
system values health states other than full health as
negative deviations from 11111 = 1, VASit (as explained
earlier, rendered on a 0-100 VAS) can be represented as
100 minus the combination of dummy variables and
their coefficients (to be estimated). This allowed the
dependent variable in equations (1) and (2) to be trans-
formed to 100 −VASit (so that higher values correspond
to ‘worse’ health states).
Consistent with the explanations above, coefficients
β1-β5 are interpretable as the decrements to a health
state’s valuation of a move from level 1 to 2 or from level
2 to 3 on the respective EQ-5D dimensions, all else be-
ing equal. Similarly, coefficient β6 in equation (2) is in-
terpretable as the extra decrement from any dimension
being at level 3 (i.e. additional to the effects captured
by β1-β5).
Ethical approval
This study was approved by the New Zealand Health
and Disability Multi-Region Ethics Committee (MEC/
07/07/093).
Results
The socio-demographic characteristics of participants in
the injured population and general population studies
are reported in Table 2. The first column for the injured
population study refers to the smaller sample whose val-
uations were included in the direct comparison of health
state valuations (i.e. people who, in at least one of the
Table 1 Dummy variables used to model health
state valuations
Mobility (MO) 0 if No problems with walking
about (level 1)
1 if Some problems with walking
about (level 2)
2 if Confined to bed (level 3)
Self-care (SC) 0 if No problems with self-care (level 1)
1 if Some problems washing or
dressing self (level 2)
2 if Unable to wash or dress
self (level 3)
Usual activities (UA) 0 if No problems with performing usual
activities (e.g. work, study, housework,
family or leisure activities) (level 1)
1 if Some problems with performing
usual activities (level 2)
2 if Unable to perform usual
activities (level 3)
Pain/discomfort (PD) 0 if No pain or discomfort (level 1)
1 if Moderate pain or discomfort (level 2)
2 if Extreme pain or discomfort (level 3)
Anxiety/depression (AD) 0 if Not anxious or depressed (level 1)
1 if Moderately anxious or depressed
(level 2)
2 if Extremely anxious or depressed
(level 3)
Any dimensions at level 3 (N3) 1 if any dimension is at level 3
0 otherwise
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cluded in the general population study), whereas the sec-
ond column refers to those whose valuations were
included in the regression analysis (i.e. those who com-
pleted the EQ-5D and VAS at least once in the three
interviews).
Of the 2856 participants recruited to the injured popula-
tion study, 2823 valued their own health on the EQ-5D at
the first interview (3-months), 1457 at the second inter-
view (5-months), and 2247 at the third interview (12-
months). These three interviews resulted in a total of 6527
valuations, covering 115 of the 243 possible EQ-5D states.
Of these 115 states, 18 matched the 23 states included in
the general population study, of which 13 were valued by
at least two participants, and so they could be included in
the present study. Table 3 reports the mean valuations for
these 13 states from the two studies.
As can be seen in Table 3, the mean health state val-
uations of the injured population are higher than the
hypothetical valuations of the general population for all
13 health states considered except 11111. This diffe-
rence, which tends to be larger the ‘worse’ the state, is
statistically significant at the 10% level for all states ex-
cept 11211, 12111, 22233 and 22323.Table 4 presents the estimates of equations (1) and (2)
for the injured population study and also, for compari-
son purposes, the general population study. For both
equations, though the five dimensions all have statisti-
cally significant effects on participants’ valuations (of the
expected positive sign), their relative magnitudes in the
respective studies are very different.
Consistent with our earlier finding (Table 3) that the in-
jured population own health valuations (means) are
mostly higher than the general population hypothetical
valuations, almost all of the estimated coefficients for both
equations are larger for the general population. For in-
jured people, the most important dimension in terms of
negative effects on valuations is self-care (SC), followed by
anxiety/depression (AD), usual activities (UA), mobility
(MO) and pain/discomfort (PD). For the general popula-
tion, AD is also an important dimension (most important);
however, in contrast to the injured population, SC is the
least or second-least important dimension (equation 1 or
2), and PD is the second most important dimension (both
equations). The additional decrement to health valuations
due to extreme problems on any dimension (N3) is much
larger in the general population than in the injured
population.
Discussion
Our finding that injured New Zealanders’ valuations of
their own health, represented using the EQ-5D system,
are mostly higher than general population valuations of
the same (hypothetical) states – with the notable excep-
tion of state 11111 (discussed below) – is consistent with
the previous international research mentioned in the
Introduction.
As discussed by Ubel et al. [24], possible reasons for
this phenomenon include: (1) the two groups are, in ef-
fect, valuing different health states albeit they are repre-
sented identically on the EQ-5D; (2) patients adapt to
their poor health states (and so value them relatively
high); (3) the ‘focussing illusion’ [25], whereby members
of the general population over-emphasise aspects of
HRQoL most affected by illness; and (4) a shift of refer-
ence points as people assess health states with reference
to their current health. See Ubel et al. for discussion of
these and other explanations.
The one exception to the finding that injured population
valuations exceed general population valuations is the
valuation for state 11111: it is lower for the injured popu-
lation than for the general population. Consistent with
reason (1) above, perhaps this is because for injured
people even when, as represented on the EQ-5D, they are
at ‘full health’, to them there are other aspects of their
health (not captured by the EQ-5D) that are sub-optimal.
Albeit the differences between the injured population
and general population valuations – in the range 3.8 to
Table 2 Socio-demographic characteristics of participants













n = 2099 n = 2847 n = 396
% % %
Sex:
Female 37.3 38.6 54.3
Male 62.7 61.4 45.0
Age:
18-19 years 3.9 3.6 2.5
20-29 22.1 21.0 14.9
30-39 23.3 22.4 21.9
40-49 21.6 22.8 22.5
50-59 21.6 22.3 17.4
60+ 7.5 7.9 20.5
Ethnicity:
European or Pakeha 68.8 67.8 86.5
Māori 18.9 19.8 7.1
Pacific islands# 6.6 6.8 1.4




Employed 93.0 91.9 64.1
Retired 0.5 0.7 15.9
Homemaker 1.5 1.4 11.6
Student 2.5 2.3 5.6
Seeking work 0.6 0.9 0.8
Other 1.9 2.8 2.0
#Samoan, Cook Island Māori, Tongan and Niuean.
Not all percentages sum to 100 because participants for whom a response
was not recorded are not reported here. In the injured population study,
participants could report more than one ethnicity.
Wilson et al. Health and Quality of Life Outcomes 2014, 12:21 Page 5 of 7
http://www.hqlo.com/content/12/1/2127.1 (Table 3) – are statistically significant, how practically
significant are they? Minimally important differences for
the EQ-5D (0-1 scale) have been estimated to be in the
range of 0.04 to 0.08 [26-28] – equivalent to 4.0 to 8.0 on
a 0-100 scale – which suggests that the above-mentioned
differences are also practically significant.
The potential implications of our results for CUA can
be illustrated via the example of a CUA of laparoscopic-
assisted colectomy (LAC) for colon cancer relative to open
colectomy (OC) undertaken by Hayes and Hansen [29].
Applying Devlin et al.’s value set [12] – as explained
earlier, derived from the general population study in-
cluded in the present study – the authors reported twosets of results corresponding to data from two randomised
control trials (RCTs): mean QALY gains of 0.018 and
0.049 per patient (depending on the RCT) and costs per
QALY of $70,389 and $25,857 respectively.
These results were based on a simple model in which
the authors of the CUA assumed that patients were in
state 22222 when discharged from hospital and 11111
when they recovered from both LAC and OC (LAC has
a quicker recovery time). State 22222 is worth 0.464 in
Devlin et al.’s value set. For the demonstration here, it is
sufficient to increase 22222’s value by 0.130, the differ-
ence between the injured population and general popu-
lation means for 22222 (see Table 3) after normalising
them to the conventional 0-1 scalea. The effect of 22222
being worth 0.594 instead of 0.464 is to lower the QALY
gains from 0.018 and 0.049 (as above) to 0.013 and 0.037
and to raise the costs per QALY from $70,389 and
$25,857 to $94,661 and $34,422 respectively. These re-
vised cost-per-QALY estimates are approximately one-
third larger than the original estimates. Although cost-
effectiveness acceptability thresholds for New Zealand
are not reported, such relatively large increases could,
conceivably, result in LAC going from being cost-effective
(if general population valuations were used) to being not
cost-effective (if patient valuations were used). Note,
though, the calculations above are intended only to illus-
trate the possible effects of differences between the injured
population and general population valuations, not to serve
as a bona fide CUA.
Strengths and weaknesses of the study
The main strength of this study is that, to the best of
our knowledge, it is the first comparison of injured peo-
ple’s valuations of their own health, represented using
the EQ-5D system, vis-à-vis general population valua-
tions of the same EQ-5D states for New Zealand.
This study has several potential weaknesses. As dis-
cussed in the Methods section, it was not possible to en-
sure that the samples employed from the general and
injured populations were similar in terms of their socio-
demographic characteristics; participants in the injured
population study were younger, more likely to be male,
employed and of Māori, Pacific Islands, Asian or ‘other’
ethnicity (not European or Pakeha). However, as also
discussed earlier, international evidence suggests that
this should not have a significant effect on health state
valuations [11,21,22]. Another potential weakness is that
the two sets of valuations are not from the same data-
gathering exercise. Instead, they were run independently,
separated in time by almost a decade (i.e. 1999 versus
2007-09). New Zealanders’ health state preferences
could, potentially, have changed over this time period;
however, the literature provides no indication as to
whether this is likely to be a serious problem. Also, the
Table 3 Mean health state valuations from the injured









11111 85.4 (1997) 96.6 (396) −11.2*** (0.4)
11112 76.9 (152) 73.2 (380) 3.8** (1.4)
11113 72.6 (5) 45.5 (131) 27.1** (8.5)
11121 81.5 (912) 73.6 (390) 7.9*** (0.8)
11122 71.9 (143) 53.8 (112) 18.0*** (2.0)
11131 79.2 (6) 53.0 (137) 26.1* (10.3)
11211 78.7 (110) 78.6 (393) 0.0 (1.7)
12111 74.0 (10) 70.2 (241) 3.8 (4.7)
21111 79.5 (85) 74.3 (388) 5.3** (1.6)
21232 46.2 (21) 32.5 (113) 13.7*** (3.7)
22222 54.9 (158) 41.9 (279) 13.1*** (1.6)
22233 46.3 (4) 22.5 (113) 23.7 (11.2)
22323 31.7 (6) 22.7 (105) 9.0 (7.4)
SE: Standard errors of the estimated mean differences.
*Significant at the 10% level; **Significant at the 5% level; ***Significant at the
1% level.
Significance levels adjusted for multiple comparisons using the
Holm-Bonferroni method.
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questionnaire whereas the injured population study, as
part of the Prospective Outcomes of Injury Study, was
mostly interviewer-administered. These differences be-
tween data collection methods have the potential to
cause information bias; again, we cannot determine the
nature or possible extent of this potential bias.Table 4 Estimates of equations (1) and (2) for the two
studies



















MO 4.06 (0.58) 7.72 (0.34) 4.16 (0.59) 6.62 (0.31)
SC 6.98 (0.66) 5.52 (0.41) 6.82 (0.67) 5.37 (0.37)
UA 5.53 (0.49) 7.06 (0.38) 5.04 (0.53) 3.09 (0.37)
PD 2.40 (0.49) 11.0 (0.29) 2.21 (0.50) 7.94 (0.28)
AD 5.61 (0.58) 11.4 (0.29) 5.37 (0.58) 8.83 (0.28)
N3 2.54 (0.98) 17.7 (0.54)
Constant 16.8 (0.35) 18.6 (0.30) 17.0 (0.36) 18.0 (0.27)
N obs. 6523 5283 6523 5283
N
individuals
2847 396 2847 396
R2 0.20 0.81 0.20 0.85
SE: Standard errors.
All coefficients are significant at the 1% level.Conclusions
Consistent with the international literature, we find that
injured people’s VAS valuations of their own health, rep-
resented using the EQ-5D system, are mostly higher
than the general population’s hypothetical valuations of
the same EQ-5D states for New Zealand. These differ-
ences are practically significant in the sense that they are
larger than minimally important differences for the EQ-
5D from the literature, and they appear capable of sig-
nificantly affecting CUA results; hence they could poten-
tially influence health technology assessments.
Our results are further evidence that it can make a dif-
ference whose health state valuations are included when
value sets are being created. However, this does not
mean, necessarily, that patients’ (or injured people’s) val-
uations should be used instead of the general popula-
tion’s. That is a whole other matter that ultimately
depends on the decision-making context and the pur-
pose of the analysis [8]. The consensus seems to be that
for decisions at the individual-patient level, such as
treatment options, the patient’s own valuations should
be used. For decisions at the aggregate level, such as
health technology assessments, value sets representing
the general population should be used.
Endnote
aNote that Devlin et al.’s value of 0.464 is not directly
comparable with the general population value in Table 3
because Devlin et al.’s value set comes from estimating
equation (2) above rather than it being a mean value,
and also because, as is conventional when estimating
values, the underlying survey valuation data were
‘rescaled’ relative to each participant’s hypothetical valu-
ations of ‘dead’ and ‘perfect health’ (which were not col-
lected in the injured population study).
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